Saskatchewan River Sturgeon Management Board

DGAP-News: Deutsche Rohstoff AG: Consolidated net income rises to EUR 21.4 million

Thursday, October 14, 2021 - 10:03am

By 30 September 2021, revenues increased by almost 65% year-on-year to EUR 53.2 million (previous year: EUR 32.3 million) and EBITDA increased by 140% to EUR 52.1 million (previous year: EUR 21.7 million).

Key Points: 
  • By 30 September 2021, revenues increased by almost 65% year-on-year to EUR 53.2 million (previous year: EUR 32.3 million) and EBITDA increased by 140% to EUR 52.1 million (previous year: EUR 21.7 million).
  • Consolidated net income after nine months amounted to EUR 21.4 million (previous year: consolidated net loss of EUR 14.3 million).
  • In the broader definition (bank balances + non-current and current securities + current receivables) cash and cash equivalents amounted to EUR 49.5 million (30 June 2021: EUR 71.3 million).
  • Equity increased to EUR 72.5 million as of 30 September 30 2021 (30 June 2021: EUR 66.2 million).

DGAP-News: 2G Energy AG: Order intake up by around 70% to EUR 43.8 million in the third quarter (previous year: EUR 26.0 million)

Thursday, October 14, 2021 - 8:02am

The production capacities expanded as part of the lead-to-lean project are thereby fully utilized until the middle of next year.

Key Points: 
  • The production capacities expanded as part of the lead-to-lean project are thereby fully utilized until the middle of next year.
  • In pursuing this course, it is intentionally accepted that these capacity expansions will temporarily result in burdens on profitability.
  • The 2G Energy AG Group is an internationally leading manufacturer of decentralized energy supply systems.
  • The shares of 2G Energy (ISIN DE000A0HL8N9) are listed in the "Scale" segment of the Frankfurt Stock Exchange.

DGAP-News: Leifheit Aktiengesellschaft: Leifheit AG sees business development burdened by global impact of the pandemic

Thursday, October 14, 2021 - 8:02am

In the third quarter of 2021, the Group achieved a turnover of EUR 69.7 million (Q3 2020: EUR 71.6 million).

Key Points: 
  • In the third quarter of 2021, the Group achieved a turnover of EUR 69.7 million (Q3 2020: EUR 71.6 million).
  • EBIT in the third quarter stood at EUR 3.0 million (Q3 2020: EUR 6.6 million).
  • In the third quarter, we have now seen that the global effects of the pandemic on the procurement market are noticeably worsening and increasingly affect the Leifheit Group's business activities.
  • This burdened EBIT in the third quarter and will also have an impact in the final quarter.

DGAP-News: SHOP APOTHEKE EUROPE: Strong growth of everything-but-Rx.

Tuesday, October 5, 2021 - 8:17am

Preliminary total sales growth stands at 9.8% for the first nine months of 2021 to EUR 772 million, on track for full-year sales growth guidance.

Key Points: 
  • Preliminary total sales growth stands at 9.8% for the first nine months of 2021 to EUR 772 million, on track for full-year sales growth guidance.
  • A negative start of Q3 due to capacity constraints was offset by recovered growth towards the end of the quarter; Q3 growth -0.3%.
  • This allows us to return to our growth trajectory and to be prepared for further growth in Q4 and 2022.
  • For the full year 2021, the Management Board of SHOP APOTHEKE EUROPE expects sales growth between 10 and 15% and an adjusted EBITDA margin around break-even.

DGAP-News: Aves One reflects on a positive first half of 2021 and confirms its 2021 full-year forecast

Thursday, September 30, 2021 - 4:20pm

Accordingly, the rail segment contributed sales of EUR 44.5 million (PY: EUR 41.2 million).

Key Points: 
  • Accordingly, the rail segment contributed sales of EUR 44.5 million (PY: EUR 41.2 million).
  • The container segment's contribution to sales amounted to EUR 5.5 million (PY: EUR 5.5 million).
  • In the first half of 2021, 216 tank and Intermodal wagons with a volume of approximately EUR 19.6 million were taken into stock.
  • Given this positive trend and the steady business development of the rail segment, the Management Board confirms the forecast for the financial year 2021.

VTB Group announces IFRS financial results for August and 8M 2021

Thursday, September 30, 2021 - 9:03am

VTB Bank, the parent company of VTB Group (the "Group"), today publishes its unaudited consolidated financial results in accordance with IFRS for August and eight months of 2021.

Key Points: 
  • VTB Bank, the parent company of VTB Group (the "Group"), today publishes its unaudited consolidated financial results in accordance with IFRS for August and eight months of 2021.
  • The Group earned RUB 231 billion in 8M 2021, which corresponds to a return on equity of 18.2%.
  • VTB Group's net profit was RUB 231.4 billion in 8M 2021 and RUB 30.5 billion in August 2021, increasing 4.4x and 3.1x, respectively, year-on-year.
  • Return on equity was 18.2% in 8M 2021 and 17.4% in August 2021, up from 4.6% and 6.8% year-on-year, respectively.

DGAP-News: Daldrup & Söhne AG increases EBIT result in H1 2021

Thursday, September 30, 2021 - 6:02am

The Group's half-year earnings before interest, taxes, depreciation and amortisation (EBITDA) as at 30 June 2021 improved slightly to 1.8 million (1.7 million).

Key Points: 
  • The Group's half-year earnings before interest, taxes, depreciation and amortisation (EBITDA) as at 30 June 2021 improved slightly to 1.8 million (1.7 million).
  • At the operating level, the Group again achieved a positive result (EBIT) of EUR 611 thousand (EUR 549 thousand), an increase of around 11 percent.
  • The Annual General Meeting of Daldrup & Shne AG on 26 August 2021 approved the administration's proposal to elect Wolfgang Bosbach as the fourth member of the Supervisory Board by a large majority.
  • The order situation in all business areas of Daldrup & Shne AG remains satisfactory.

DGAP-News: The Grounds Real Estate Development AG significantly expands operative business and resolves a further capital market measure

Wednesday, September 29, 2021 - 5:07pm

Berlin, 29.09.2021 - In the first half-year of 2021, The Grounds Real Estate Development AG (The Grounds / ISIN: DE000A2GSVV5) strongly increased its consolidated sales revenues to EUR 4.9 million (previous year: EUR 0.6 million).

Key Points: 
  • Berlin, 29.09.2021 - In the first half-year of 2021, The Grounds Real Estate Development AG (The Grounds / ISIN: DE000A2GSVV5) strongly increased its consolidated sales revenues to EUR 4.9 million (previous year: EUR 0.6 million).
  • It was also possible to increase rental incomes by 26.7% to EUR 695 thousand (previous year: EUR 548 thousand) by further expansion of the real estate portfolio.
  • Consolidated profits before taxes and interest (EBIT) of EUR 1.6 million were 13.3% above the previous year's level.
  • The demand for owner-occupied apartments remains high, and is reflected in the current notarisations and reservations soon after the start of marketing.

DGAP-News: CytoTools Reports Progress of DermaPro(R) Phase III Study in Europe and Provides Operational Status Update

Wednesday, September 29, 2021 - 11:03am

Darmstadt, 29 September 2021 - CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding company specializing in pharmaceutical and medical products, provides a status update on the progress of key development projects and the operational business development in advance of its virtual Annual General Meeting to be held tomorrow.

Key Points: 
  • Darmstadt, 29 September 2021 - CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding company specializing in pharmaceutical and medical products, provides a status update on the progress of key development projects and the operational business development in advance of its virtual Annual General Meeting to be held tomorrow.
  • The Phase III trial of DermaPro(R)in Europe, which started at the end of 2020, is progressing increasingly according to plan after a slow start.
  • Thus, the completion of the recruitment phase could still be achieved in Q4 2022 without further delays.
  • Further information on CytoTools AG, its affiliated subsidiaries and the holding company's drug pipeline is available on the company's website at www.cytotools.de.

DGAP-News: Formycon Reports on Virtual Annual General Meeting 2021

Monday, September 27, 2021 - 4:09pm

Press Release // September 27, 2021

Key Points: 
  • Press Release // September 27, 2021
    Munich - Formycon AG (ISIN: DE000A1EWVY8/ WKN: A1EWVY) held its Annual General Meeting on September 27, 2021 - for the protection of all persons involved - in virtual form.
  • The shareholders were able to follow the virtual Annual General Meeting live in picture and sound via the Company's AGM portal.
  • They followed the proposals of the Management Board and Supervisory Board and approved all the resolutions proposed by the management with large majorities.
  • Voting rights could be executed before and during the virtual Annual General Meeting by postal vote or by authorizing the Company's proxies.